Back
Theriva Biologics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
TOVX
Theriva Biologics, Inc.
Last Price:
$0.19
Seasonality Move:
18281.59%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight buying pressure.
Theriva Biologics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.2 | Sell |
| 20-day SMA: | 0.22 | Sell |
| 50-day SMA: | 0.29 | Sell |
| 200-day SMA: | 0.58 | Sell |
| 8-day EMA: | 0.1 | Buy |
| 20-day EMA: | 0.05 | Buy |
| 50-day EMA: | 0.02 | Buy |
| 200-day EMA: | 0.01 | Buy |
Theriva Biologics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 40.46 | Sell |
| Chaikin Money Flow: | 2037023 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.2 - 0.24) | Sell |
| Bollinger Bands (100): | (0.25 - 0.45) | Sell |
Theriva Biologics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theriva Biologics, Inc. Stock
Is Theriva Biologics, Inc. Stock a Buy?
-
Theriva Biologics, Inc. share price is 0.19 while TOVX 8-day simple moving average is 0.20, which is a Sell signal.
-
The stock price of TOVX is 0.19 while Theriva Biologics, Inc. 20-day SMA is 0.22, which makes it a Sell.
-
Theriva Biologics, Inc. 50-day simple moving average is 0.29 while TOVX share price is 0.19, making it a Sell technically.
-
TOVX stock price is 0.19 and Theriva Biologics, Inc. 200-day simple moving average is 0.58, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
18
Theriva Biologics, Inc. (TOVX)
is a Sell
Is Theriva Biologics, Inc. a Buy or a Sell?
-
Theriva Biologics, Inc. stock is rated a SellThe current Theriva Biologics, Inc. [TOVX] share price is $0.19. The Score for TOVX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics, Inc. Stock Info
Market Cap:
6.4M
Price in USD:
0.19
Share Volume:
5.1M
Theriva Biologics, Inc. 52-Week Range
52-Week High:
2.08
52-Week Low:
0.17
Sell
18
Theriva Biologics, Inc. (TOVX)
is a Sell
Theriva Biologics, Inc. Share Price Forecast
-
What is the Theriva Biologics, Inc. stock price today?The Theriva Biologics, Inc. stock price is 0.19 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics, Inc. is overvalued.
Is Theriva Biologics, Inc. Stock a Buy?
-
Theriva Biologics, Inc. share price is 0.19 while TOVX 8-day exponential moving average is 0.10, which is a Buy signal.
-
The stock price of TOVX is 0.19 while Theriva Biologics, Inc. 20-day EMA is 0.05, which makes it a Buy.
-
Theriva Biologics, Inc. 50-day exponential moving average is 0.02 while TOVX share price is 0.19, making it a Buy technically.
-
TOVX stock price is 0.19 and Theriva Biologics, Inc. 200-day simple moving average is 0.01, creating a Buy signal.
Fundamental Analysis of Theriva Biologics, Inc.
Is Theriva Biologics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.60 per share, and an increase next year of $1.40 per share.
Technical Analysis of Theriva Biologics, Inc.
Should I short Theriva Biologics, Inc. stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Theriva Biologics, Inc. is a Buy
-
Theriva Biologics, Inc. Relative Strength Index (RSI) is 40.46, which suggest Theriva Biologics, Inc. is oversold
-
The Bollinger Bands (25) for Theriva Biologics, Inc. is (0.2 - 0.24), which suggest Theriva Biologics, Inc. is a Sell
-
The Bollinger Bands (100) for Theriva Biologics, Inc. is (0.25 - 0.45), which suggest Theriva Biologics, Inc. is a Sell
* Theriva Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.